M

MedPacto Inc
KOSDAQ:235980

Watchlist Manager
MedPacto Inc
KOSDAQ:235980
Watchlist
Price: 6 340 KRW -1.09%
Market Cap: 217.3B KRW

Intrinsic Value

The intrinsic value of one MedPacto Inc stock under the Base Case scenario is 239.49 KRW. Compared to the current market price of 6 340 KRW, MedPacto Inc is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
239.49 KRW
Overvaluation 96%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
MedPacto Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about MedPacto Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MedPacto Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for MedPacto Inc.

Explain Valuation
Compare MedPacto Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MedPacto Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MedPacto Inc

Current Assets 51.6B
Cash & Short-Term Investments 48.4B
Receivables 1.8B
Other Current Assets 1.5B
Non-Current Assets 3.8B
Long-Term Investments 4.1m
PP&E 2.8B
Intangibles 236.9m
Other Non-Current Assets 753.7m
Current Liabilities 1.4B
Accounts Payable 50.4m
Accrued Liabilities 203.7m
Other Current Liabilities 1.2B
Non-Current Liabilities 1.6B
Other Non-Current Liabilities 1.6B
Efficiency

Free Cash Flow Analysis
MedPacto Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MedPacto Inc

Revenue
1.3B KRW
Cost of Revenue
-1.2B KRW
Gross Profit
118m KRW
Operating Expenses
-13.5B KRW
Operating Income
-13.3B KRW
Other Expenses
1.5B KRW
Net Income
-11.8B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

MedPacto Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low Gross Margin
Negative 3Y Average Gross Margin
23/100
Profitability
Score

MedPacto Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

MedPacto Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

MedPacto Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
MedPacto Inc

There are no price targets for MedPacto Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

MedPacto Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MedPacto Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MedPacto Inc stock?

The intrinsic value of one MedPacto Inc stock under the Base Case scenario is 239.49 KRW.

Is MedPacto Inc stock undervalued or overvalued?

Compared to the current market price of 6 340 KRW, MedPacto Inc is Overvalued by 96%.

Back to Top